Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
FICO has staged a 15% weekly bounce to $681.77, yet analysts filed fresh target cuts even as the stock was recovering, a tension that captures where the stock sits one month into one of the sharpest de-ratings in the software sector.
The short squeeze angle is now genuinely interesting. Short interest has been falling steadily, dropping 7.2% across the week to 7.2% of the free float, or roughly 1.71 million shares. That decline has been running for several weeks and aligns with the rally: shorts have been covering, not adding. The borrow market confirms the shift. Availability has loosened dramatically, reaching 1,174% by October 7, the highest reading in the past 52 weeks (the prior minimum was 194%). In practical terms, shares to borrow are now abundant relative to the number actually shorted. Cost to borrow has come down too, easing 17% across the week to 0.41%. The ORTEX short score has fallen from 54.2 a week ago to 46.4, moving below the neutral 50 mark and signalling the short-side pressure is diminishing. Options positioning is less defensive than recent weeks. The put/call ratio has pulled back to 0.76, nearly a standard deviation below its 20-day mean of 0.82, meaning calls have outpaced puts into this week's rally. It is a notable shift: through September the ratio was persistently above 0.90.
The Street picture is messier. Two analyst actions this week reinforced the downward target trend that began on September 30. Wells Fargo's Jason Haas, who has now cut three times in three weeks, moved again to $800 from $950 while holding Overweight. Barclays moved to $875 from $935, also keeping Overweight. Both cuts happened as the stock was bouncing, not falling. The mean target has drifted to roughly $1,113, against a price of $681. That gap has narrowed somewhat from the two-to-one ratio flagged in the previous notes, but it remains extreme. EPS momentum factor scores are among the highest in the universe at 94 on a 30-day basis and 84 on a 90-day, suggesting the earnings revision picture has not collapsed the way the stock price has. The PE multiple has compressed sharply over the past 30 days, now at 12x, while the EV/EBITDA of 9.2x is down about 1.2 turns over the same period. The bear case centres on VantageScore gaining ground after FHFA's decision to allow it for GSE mortgages, which directly threatens the premium embedded in FICO's Scores franchise pricing. The bull case rests on the software segment, where ARR was up 49% and net retention at 109% in the most recent quarter.
Retail attention is running at its highest level in months. The ORTEX alt data layer shows a Wikipedia views z-score of 2.4 as of October 1, meaning traffic to FICO's page is well above its own 90-day average. That is an attention measure rather than a revenue signal, but it tracks with the short covering and the call buying: more participants are looking at this name as a potential recovery candidate.
Capital Research and Management, FICO's largest institutional holder at 15.1% of shares, added 702,618 shares in the quarter to September 30. That is a material addition from a concentrated, active owner and represents the clearest institutional conviction signal in the current data. BlackRock and State Street made smaller additions. Valley Forge Capital, another active holder, trimmed by 97,000 shares as of June 30. The insider log is less instructive this week. The most recent open-market activity predates the July crash, and the 90-day net position is marginal. CEO William Lansing exercised options in June and withheld shares for taxes, standard mechanics that carry no directional read.
Earnings are scheduled for November 6. The two most recent prints produced first-day moves of minus 15% and minus 8%, with five-day losses of 18% and 9% respectively. Whether the partial short-covering and improved options tone represent genuine re-rating or just a tactical bounce is what the next print will test.
See the live data behind this article on ORTEX.
Open FICO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
